south korea breast cancer market

South Korea Breast Cancer Market: Segmented By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Surgery, Medication), By Mechanism Of Action (HER2 Inhibitors, Mitotic Inhibitors, Anti-metabolites, Aromatase Inhibitors, CDK 4/6 Inhibitors, Hormonal Receptor and Others), and By Drug Type (Herceptin Hylecta, Atezolizumab, Talazoparib, Ribociclib, Abemaciclib, Neratinib, Palbociclib and Others)- Growth, Trends and Forecasts (2019 2028)

  • Published Date: 2022-12-13
  • Report ID: 141713
  • Pages: 200
  • Format: prudent report format

Report Overview

The South Korea breast cancer market size stood at around USD xx billion in 2019 and is projected to reach xx billion by 2028, exhibiting a CAGR of around 5.4 % during the forecast period.

Brest cancer is type of cancer that develops in breast tissue. Formation of lump in a breast, red patches on the skin are the some of the common symptoms of the breast cancer. Obesity, lack of physical exercise, overexposure to radiation and drinking alcohol are some of the risk factor for developing breast cancer. It is the second most common type of cancer in women. It accounted for 23.7% of new cancer cases in females of South Korea in 2020.



Market Drivers

In Korea, breast cancer is the most common among all cancers in women. In 2017, there were 22,300 new cases and the crude incidence rate was 86.9 per 100,000, according to data from the Korea National Cancer Incidence Database (KNCID). The number of incident breast cancers in 2019 was estimated to be at 24,010, with a crude incidence rate of 92.9 per 100,000, suggesting an increasing trend. An epidemiologic study suggests that the incidence rate is expected to rapidly increase within the next 10 years in Korea due to an increasing proportion of older individuals in the population and continuous adoption of the westernized lifestyle.


1. South Korea Breast Cancer Market Overview
A. Market Size
2. Market Growth Drivers.
A. Rising Geriatric Population
B. Adoption of Westernised Lifestyle
3. Types of Breast Cancer.........................................................
A. Invasive Ductal Carcinoma
B. Invasive Lobular Carcinoma
C. Inflammatory Breast Cancer
D. Paget's Disease Of The Breast
E. Angiosarcoma Of The Breast
4. Breast Cancer Market Segmentation.
A. Treatment Type
I. Chemotherapy
II. Targeted Therapy
III. Immunotherapy
IV. Surgery
V. Medication
B. Mechanism Of Action
I. HER2 Inhibitors
II. Mitotic Inhibitors
III. Anti-metabolites
IV. Aromatase Inhibitors
V. CDK 4/6 Inhibitors
VI. Hormonal Receptor
VII. Others
C. Drug Type
I. Herceptin Hylecta
II. Atezolizumab
III. Talazoparib
IV. Ribociclib
V. Abemaciclib
VI. Neratinib
VII. Palbociclib
VIII. Others
5. Breast Cancer Products Market Share.
A. Market Analysis, Insights and Forecast By Revenue
6. Competitive Landscape...
A. Major Players
B. Products in Pipeline
7. Key Company Profiles.
A. Novartis Korea Company Overview, Product & Services, Strategies & Financials
B. Bixink Company Overview, Product & Services, Strategies & Financials
C. Celltrion Company Overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth
A. New Trends and Development of Breast Cancer Market
B. Future Opportunities
10. Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.